Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

EQS-Adhoc : Medacta Group SA reports 35.4% growth -2-

07/20/2021 | 01:01am EDT

Contact Medacta International SA Gianna La Rana, Head of Investor Relations Phone: +41 91 696 14 95 investor.relations@medacta.ch About Medacta Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta's innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.

Disclaimer This press release has been prepared by Medacta Group SA ('Medacta' and together with its subsidiaries, 'we', 'us' or the 'Group'). The information contained in the press release does not purport to be comprehensive and is not to be taken as containing any securities advice, recommendation, offer or invitation to subscribe for, purchase or redeem any securities regarding Medacta. Forward-looking information This press release has been prepared by Medacta and includes forward-looking information and statements concerning the outlook for its business. These statements are based on current expectations, estimates and projections about the factors that may affect its future performance. These expectations, estimates and projections are generally identifiable by statements containing words such as 'expects', 'believes', 'estimates', 'targets', 'plans', 'outlook' or similar expressions. Although Medacta believes that its expectations reflected in any such forward-looking statement are based upon reasonable assumptions, it can give no assurance that those expectations will be achieved.

Alternative Performance Measures This press release contains certain information that it refers to as "constant currency", which is a non-IFRS financial measure and represents the total change between periods excluding the effect of changes in foreign currency exchange rates. The Group believes that the reconciliations of changes in constant currency provide useful supplementary information to investors in light of fluctuations in foreign currency exchange rates. Furthermore, the Group believes that constant currency measures provide additional useful information on the Group's operational performance and is consistent with how the business performance is measured internally. ----------------------------------------------------------------------------------------------------------------------- End of ad hoc announcement -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      Medacta Group SA 
              Strada Regina 
              6874 Castel San Pietro 
              Switzerland 
Phone:        +41 91 696 6060 
E-mail:       info@medacta.ch 
Internet:     www.medacta.com 
ISIN:         CH0468525222 
Listed:       SIX Swiss Exchange 
EQS News ID:  1220051 
 
End of Announcement EQS Group News Service 
=------------ 

1220051 20-Jul-2021 CET/CEST

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1220051&application_name=news 
 

(END) Dow Jones Newswires

July 20, 2021 01:00 ET (05:00 GMT)

All news about MEDACTA GROUP SA
09/16MEDACTA : celebrates the milestone of 10,000 Medacta Shoulder System implanted w..
PU
09/14MEDACTA : Credit Suisse Lifts Price Target on Medacta Group, Maintains Neutral R..
MT
09/10MEDACTA : Swiss Medical Device Maker Medacta's H1 Profit Climbs as All Business ..
MT
09/10MEDACTA : reports strong profitability with 31.9% adjusted EBITDA margin in the ..
PU
09/10MEDACTA : Press Release – 2021 Half-Year Results
PU
09/10MEDACTA : 2021 Half-Year Report
PU
09/10MEDACTA : 2021 Half-Year Presentation
PU
09/10Medacta reports strong profitability -2-
DJ
09/10Medacta reports strong profitability with 31.9% adjusted EBITDA margin in the..
DJ
09/10Medacta Group SA Confirms Revenue Guidance for the Year 2021
CI
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Financials
Sales 2021 348 M 407 M 407 M
Net income 2021 56,0 M 65,6 M 65,6 M
Net Debt 2021 83,5 M 97,8 M 97,8 M
P/E ratio 2021 49,7x
Yield 2021 0,54%
Capitalization 2 783 M 3 270 M 3 260 M
EV / Sales 2021 8,24x
EV / Sales 2022 7,15x
Nbr of Employees 1 246
Free-Float 30,5%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 139,16 €
Average target price 107,02 €
Spread / Average Target -23,1%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA73.74%3 270
ABBOTT LABORATORIES15.80%224 776
MEDTRONIC PLC10.72%174 552
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839